CN104096133A - Medicament for treating chloasma - Google Patents

Medicament for treating chloasma Download PDF

Info

Publication number
CN104096133A
CN104096133A CN201410390860.0A CN201410390860A CN104096133A CN 104096133 A CN104096133 A CN 104096133A CN 201410390860 A CN201410390860 A CN 201410390860A CN 104096133 A CN104096133 A CN 104096133A
Authority
CN
China
Prior art keywords
parts
rhizoma
radix
chloasma
medicine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201410390860.0A
Other languages
Chinese (zh)
Inventor
宋德成
邸克莱
刘彩田
王磊
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tianjin Pacific Pharmaceutical Co Ltd
Original Assignee
Tianjin Pacific Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tianjin Pacific Pharmaceutical Co Ltd filed Critical Tianjin Pacific Pharmaceutical Co Ltd
Priority to CN201410390860.0A priority Critical patent/CN104096133A/en
Publication of CN104096133A publication Critical patent/CN104096133A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention provides a medicament for treating chloasma. The medicament comprises dahurian angelica root, cassia seed, Chinese thorowax root, coix seed, Chinese angelica, large-head atractylodes rhizome, Chinese yam, Szechuan lovage rhizome, white paeony root and stiff silkworm. The medicament has the beneficial effects that by using the medicinal materials together, the effects of invigorating spleen, supplementing qi, soothing liver-qi stagnation, regulating qi and blood and supplementing liver and kidney can be achieved, and chloasma is treated fundamentally. The medicament has a remarkable curative effect, is safe, and does not have any side effect.

Description

A kind of medicine for the treatment of chloasma
 
Technical field
The invention belongs to the field of Chinese medicines, especially relate to a kind of medicine for the treatment of chloasma.
Background technology
chloasma is the face that is mainly in young and middle-aged women face, how because of female incretion imbalance, stress is large, in various diseases and body, lack a kind of disease that vitamin or trace element cause, having a strong impact on women's appearance and personality, treatment mostly at present is dietetic therapy, medicine or cosmetics treatment, and how undesirable effect is.
Summary of the invention
The object of this invention is to provide the medicine of the treatment chloasma that a kind of therapeutic effect is good, effective percentage is high, human body is had no side effect.
Technical scheme of the present invention is: a kind of medicine for the treatment of chloasma, comprise the Radix Angelicae Dahuricae, Semen Cassiae, Radix Bupleuri, Semen Coicis, Radix Angelicae Sinensis, the Rhizoma Atractylodis Macrocephalae, Rhizoma Dioscoreae, Rhizoma Chuanxiong, the Radix Paeoniae Alba, Bombyx Batryticatus, and wherein the ratio of weight and number of each component is:
Radix Angelicae Dahuricae 15-25 part
Semen Cassiae 10-20 part
Radix Bupleuri 12-18 part
Semen Coicis 10-16 part
Radix Angelicae Sinensis 20-30 part
Rhizoma Atractylodis Macrocephalae 12-20 part
Rhizoma Dioscoreae 15-25 part
Rhizoma Chuanxiong 8-15 part
Radix Paeoniae Alba 9-18 part
Bombyx Batryticatus 6-12 part
Preferably, the ratio of weight and number of above-mentioned raw materials is:
18 parts of the Radixs Angelicae Dahuricae
15 parts of Semen Cassiaes
16 parts of Radix Bupleuri
12 parts of Semen Coiciss
25 parts of Radix Angelicae Sinensis
18 parts of the Rhizoma Atractylodis Macrocephalaes
17 parts of Rhizoma Dioscoreaes
10 parts of Rhizoma Chuanxiongs
12 parts of the Radix Paeoniae Albas
10 parts of Bombyx Batryticatus
Be prepared into the method for powder, said medicine is cleaned to mix homogeneously according to parts by weight, pulverize, cross 120 mesh sieves, the medicated powder after sieving is cured to sealing in marmite and dry 30 minutes, sterilizing, obtains powder finished product.
The traditional Chinese medical science think chloasma be because deficiency of both vital energy and Yin, lung stomach hot and suffocating, have a delicate constitution, belong to caused by liver and kidney deficiency, asthenia of essence and blood, blood stasis is stagnated, and gathers face and forms.The mainly medicine treatment of, pathogenic fire reducing removing heat from blood hot and suffocating with supplementing QI and nourishing YIN, lung heat clearing stomach, invigorating the liver and kidney and blood circulation promoting and blood stasis dispelling in treatment.
The Radix Angelicae Dahuricae in the present invention: pungent, warm, return lung, stomach warp, cold expelling is sensible, circulation of qi promoting promoting the circulation of blood.Semen Cassiae: liver heat removing and eyesight improving, beneficial nourishing liver-YIN.Radix Bupleuri: evacuate and bring down a fever, yang invigorating soothing liver-QI.Semen Coicis: spleen invigorating invigorating middle warmer, control damp.Radix Angelicae Sinensis: tonifying blood and regulating menstruation, promoting blood circulation and stopping pain.The Rhizoma Atractylodis Macrocephalae: replenishing QI to invigorate the spleen, strengthening superficial resistance to stop perspiration.Rhizoma Dioscoreae: invigorating the spleen and replenishing QI, transporting damp-phlegm.Rhizoma Chuanxiong: blood circulation promoting and blood stasis dispelling, promoting the circulation of QI to relieve pain.The Radix Paeoniae Alba: harmonizing yingfen and weifen, nourishing blood to suppress the hyperactive liver.Bombyx Batryticatus: dispelling pathogenic wind and eliminating phlegm, hard masses softening and resolving.
For further investigating the curative effect of this medicine, 80 patients are carried out to clinical observation, 80 patients are divided into two groups, 40 of matched groups, 40 of experimental grouies, matched group patient oral vitamin every day C, three times on the one 7 days is a course for the treatment of, experimental group patient takes powder of the present invention every day, three times on the one 7 days is a course for the treatment of, after six courses for the treatment of, adds up clinical test results.
Effective: area of chloasma diminishes or color shoals.
Cure: with the naked eye can't see chloasma, substantially disappear.
Invalid: area of chloasma does not dwindle, color does not shoal.
? Effectively Cure Invalid Total obvious effective rate
Experimental group 12 18 10 75%
Matched group 15 5 20 50%
 
Advantage and good effect that the present invention has are: all medicines share, and can play invigorating the spleen and benefiting QI, dispersing the stagnated live-QI to relieve the stagnation of QI, and QI and blood regulating, the effect of supplement Liver and kidney, fundamentally treats yellowbird speckle, evident in efficacy, and safety has no side effect.
Detailed description of the invention
Below in conjunction with specific embodiment, the invention will be further described, but do not limit the present invention.
embodiment 1
Treat a medicine for chloasma, comprise the Radix Angelicae Dahuricae, Semen Cassiae, Radix Bupleuri, Semen Coicis, Radix Angelicae Sinensis, the Rhizoma Atractylodis Macrocephalae, Rhizoma Dioscoreae, Rhizoma Chuanxiong, the Radix Paeoniae Alba, Bombyx Batryticatus, wherein the ratio of weight and number of each component is:
18 parts of the Radixs Angelicae Dahuricae
15 parts of Semen Cassiaes
16 parts of Radix Bupleuri
12 parts of Semen Coiciss
25 parts of Radix Angelicae Sinensis
18 parts of the Rhizoma Atractylodis Macrocephalaes
17 parts of Rhizoma Dioscoreaes
10 parts of Rhizoma Chuanxiongs
12 parts of the Radix Paeoniae Albas
10 parts of Bombyx Batryticatus
Said medicine is cleaned to mix homogeneously according to parts by weight, pulverize, cross 120 mesh sieves, the medicated powder after sieving is cured to sealing in marmite and dry 30 minutes, sterilizing, obtains powder finished product 1.
embodiment 2
Treat a medicine for chloasma, comprise the Radix Angelicae Dahuricae, Semen Cassiae, Radix Bupleuri, Semen Coicis, Radix Angelicae Sinensis, the Rhizoma Atractylodis Macrocephalae, Rhizoma Dioscoreae, Rhizoma Chuanxiong, the Radix Paeoniae Alba, Bombyx Batryticatus, wherein the ratio of weight and number of each component is:
20 parts of the Radixs Angelicae Dahuricae
16 parts of Semen Cassiaes
15 parts of Radix Bupleuri
13 parts of Semen Coiciss
26 parts of Radix Angelicae Sinensis
15 parts of the Rhizoma Atractylodis Macrocephalaes
20 parts of Rhizoma Dioscoreaes
12 parts of Rhizoma Chuanxiongs
10 parts of the Radix Paeoniae Albas
9 parts of Bombyx Batryticatus
Said medicine is cleaned to mix homogeneously according to parts by weight, pulverize, cross 120 mesh sieves, the medicated powder after sieving is placed in to marmite sealing and dries 30 minutes, sterilizing, obtains powder finished product 2.
Above one embodiment of the present of invention are had been described in detail, but described content is only preferred embodiment of the present invention, can not be considered to for limiting practical range of the present invention.All equalization variation and improvement etc. of doing according to the present patent application scope, within all should still belonging to patent covering scope of the present invention.

Claims (3)

1. a medicine for the treatment of chloasma, is characterized in that: comprise the Radix Angelicae Dahuricae, Semen Cassiae, Radix Bupleuri, Semen Coicis, Radix Angelicae Sinensis, the Rhizoma Atractylodis Macrocephalae, Rhizoma Dioscoreae, Rhizoma Chuanxiong, the Radix Paeoniae Alba, Bombyx Batryticatus, wherein the ratio of weight and number of each component is:
Radix Angelicae Dahuricae 15-25 part
Semen Cassiae 10-20 part
Radix Bupleuri 12-18 part
Semen Coicis 10-16 part
Radix Angelicae Sinensis 20-30 part
Rhizoma Atractylodis Macrocephalae 12-20 part
Rhizoma Dioscoreae 15-25 part
Rhizoma Chuanxiong 8-15 part
Radix Paeoniae Alba 9-18 part
Bombyx Batryticatus 6-12 part.
2. a kind of medicine for the treatment of chloasma according to claim 1, is characterized in that: the ratio of weight and number of above-mentioned raw materials is:
18 parts of the Radixs Angelicae Dahuricae
15 parts of Semen Cassiaes
16 parts of Radix Bupleuri
12 parts of Semen Coiciss
25 parts of Radix Angelicae Sinensis
18 parts of the Rhizoma Atractylodis Macrocephalaes
17 parts of Rhizoma Dioscoreaes
10 parts of Rhizoma Chuanxiongs
12 parts of the Radix Paeoniae Albas
10 parts of Bombyx Batryticatus.
3. the method for preparation a kind of medicine for the treatment of chloasma claimed in claim 1, is characterized in that: said medicine is cleaned to mix homogeneously according to parts by weight, pulverize, cross 120 mesh sieves, medicated powder after sieving is cured to sealing in marmite and dry 30 minutes, sterilizing, obtains powder finished product.
CN201410390860.0A 2014-08-11 2014-08-11 Medicament for treating chloasma Pending CN104096133A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201410390860.0A CN104096133A (en) 2014-08-11 2014-08-11 Medicament for treating chloasma

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201410390860.0A CN104096133A (en) 2014-08-11 2014-08-11 Medicament for treating chloasma

Publications (1)

Publication Number Publication Date
CN104096133A true CN104096133A (en) 2014-10-15

Family

ID=51664924

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201410390860.0A Pending CN104096133A (en) 2014-08-11 2014-08-11 Medicament for treating chloasma

Country Status (1)

Country Link
CN (1) CN104096133A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105147791A (en) * 2015-10-13 2015-12-16 赵屏 Quick-acting traditional Chinese medicine composition for treating skin diseases of acnes and chloasma

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105147791A (en) * 2015-10-13 2015-12-16 赵屏 Quick-acting traditional Chinese medicine composition for treating skin diseases of acnes and chloasma

Similar Documents

Publication Publication Date Title
CN103212040B (en) Chinese medicinal composition for treatment of seborrheic alopecia
CN102284051B (en) Medicine for treating chloasma
CN100998838A (en) Chinese medicine for relaxing muscles and tendons to promote blood circulation preparation method thereof
CN101322789A (en) Medicinal liquor prescription for treating rheumatism and rheumatoid
CN103860675A (en) Composition for treating rheumatoid arthritis
CN103301328B (en) Trigeminal neuralgia treatment medicine
CN103239656B (en) Traditional Chinese medicine for treating psoriasis
CN103623247A (en) Medicine for treating dizziness
CN103816485A (en) Traditional Chinese medicine composition for treating scleredema neonatorum and preparation method of traditional Chinese medicine composition
CN103830591A (en) Traditional Chinese medicine formula for treating stroke and post-traumatic brain syndrome and preparation method of traditional Chinese medicine
CN104096133A (en) Medicament for treating chloasma
CN103007214A (en) Chinese medicinal composition for treating palpitation
CN103083616A (en) Traditional Chinese medicine for treating ovarian cyst
CN104922410A (en) TCM (traditional Chinese medicine) preparation for treating porcine circovirus disease
CN105311460A (en) Traditional Chinese medicine for treating vascular neuralgia headache
CN104042839A (en) Traditional Chinese medicine composition for treating tinea versicolor
CN103536892B (en) Traditional Chinese medicine for treating infertility of syndrome of yang deficiency and coagulated cold
CN103860735B (en) The Chinese medicine, Chinese medicine composition and preparation method thereof for the treatment of sciatica and lumbago
CN102727740A (en) Medicine for treating alopecia
CN101983712A (en) Novel medicament for treating coronary heart disease
CN102787054B (en) Wind-dispelling healthcare liquor
CN106511964A (en) Traditional Chinese medicine composition for treating varicose vein of lower limbs
CN105168947A (en) Traditional Chinese medicine composition for treating hypochondriac pain with syndrome of liver-yin deficiency
CN106166181A (en) The local topical Traditional Chinese medicinal liquor for the treatment of arthralgia due to wind-cold-dampness disease
CN105288511A (en) Traditional Chinese medicine composition for treating scapulohumeral periarthritis and preparation method thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20141015

WD01 Invention patent application deemed withdrawn after publication